Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Moodys
Johnson and Johnson
US Department of Justice
Mallinckrodt
Queensland Health
Teva
Argus Health
Fish and Richardson

Generated: May 23, 2018

DrugPatentWatch Database Preview

Details for Patent: RE39861

« Back to Dashboard

Summary for Patent: RE39861
Title:Methods of extended use oral contraception
Abstract:A method of female contraception involves administering a combination of estrogen and progestin for 60-110 consecutive days in which the daily amounts of estrogen and progestin are equivalent to about 5-35 mcg of ethinyl estradiol and about 0.025 to 10 mg of norethindrone acetate, respectively. The advantages include less menstrual bleeding, less patient anemia, less total exposure to medication, higher compliance rates and more lifestyle convenience for patients.
Inventor(s): Hodgen; Gary D. (Virginia Beach, VA)
Assignee: Duramed Pharmaceuticals, Inc. (Pomona, NY)
Application Number:10/893,795
Patent Claim Types:
see list of patent claims
Use; Device;

Drugs Protected by US Patent RE39861

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Family Members for US Patent RE39861

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 216241 ➤ Try a Free Trial
Canada 2256977 ➤ Try a Free Trial
Canada 2596416 ➤ Try a Free Trial
Germany 69804918 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Federal Trade Commission
Cerilliant
Colorcon
Fish and Richardson
UBS
Chubb
QuintilesIMS
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.